Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Scleroderma
|
NIAMS
|
1K23AR055667-01
|
|
T cell response in scleroderma lung disease: from pathogenesis to clinical care
|
BOIN, FRANCESCO
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$124,740
|
Scleroderma
|
NHLBI
|
5R01HL080119-04
|
|
alpha2C Adrenergic Receptors & Cutaneous Circulation
|
FLAVAHAN, NICHOLAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$349,879
|
Scleroderma
|
NIAID
|
5R01AI055737-05
|
|
Molecular studies on the role of IL4 & IL13 in fibrosis
|
BONA, CONSTANTIN
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$315,326
|
Scleroderma
|
NHLBI
|
1R21HL088087-01A1
|
|
Mechanism of vascular alpha2C-adrenoceptor mobilization
|
CHOTANI, MAQSOOD
|
OHIO STATE UNIVERSITY
|
OH
|
$225,000
|
Scleroderma
|
NIAMS
|
5R01AR042309-16
|
|
MOLECULAR BASIS: REGULATION OF COLLAGEN BY TGF-BETA
|
VARGA, JOHN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$301,322
|
Scleroderma
|
NHLBI
|
1F32HL091654-01
|
|
The role of IGF-II in scleroderma-associated pulmonary fibrosis
|
HSU, EILEEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$54,842
|
Scleroderma
|
NIAID
|
5R01AI041721-11
|
|
Pregnancy, Microchimerism, and Autoimmune Disease
|
NELSON, J.
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$436,230
|
Scleroderma
|
NIAMS
|
5K01AR051052-04
|
|
CTGF-interacting proteins in scleroderma lung fibrosis
|
BOGATKEVICH, GALINA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$122,419
|
Scleroderma
|
NIAMS
|
5K23AR052742-04
|
|
Biomarkers of Vascular Disease in Scleroderma
|
HUMMERS, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$121,338
|
Scleroderma
|
NIAMS
|
5K01AR054143-02
|
|
Anti-fibrotic and anti-inflammatory roles of caveolin-1 in lung disease
|
TOURKINA, ELENA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$114,777
|
Scleroderma
|
NIA
|
5R01AG010215-13
|
|
Characterization of Lysyl Hydroxylase Isoforms in Skin
|
YEOWELL, HEATHER
|
DUKE UNIVERSITY
|
NC
|
$304,315
|
Scleroderma
|
NIAMS
|
1R15AR055355-01A1
|
|
Molecular Mechanisms of Extracellular Matrix Abnormality in Scleroderma
|
AGAH, AZIN
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$182,160
|
Scleroderma
|
NIDCR
|
5K08DE016609-04
|
|
Tissue-Specific Regulation of CTGF by Prostaglandin E2
|
BLACK, SAMUEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$128,493
|
Scleroderma
|
NHLBI
|
1R01HL089779-01A1
|
|
Inflammation, fibrosis and myocardial function in schleroderma
|
WEIHRAUCH, DOROTHEE
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$378,750
|
Scleroderma
|
NIDCR
|
5R21DE017360-02
|
|
Oral Health in People with Systemic Sclerosis
|
YUEN, HON
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$216,591
|
Scleroderma
|
NIAMS
|
5U01AR055063-02
|
|
Microarray biomarkers of disease activity and progression in systemic sclerosis
|
LAFYATIS, ROBERT
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$206,382
|
Scleroderma
|
NIAMS
|
2R01AR042334-14
|
|
The molecular mechanisms of fibrosis
|
TROJANOWSKA, MARIA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$321,200
|
Scleroderma
|
NIAMS
|
5R01AR019616-30
|
|
Biochemical and Vascular Alterations in Scleroderma
|
JIMENEZ, SERGIO
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$402,887
|
Scleroderma
|
NIAMS
|
5R01AR051089-04
|
|
Altered elastogenesis by Tsk fibrillin-1 and in SSc
|
LAFYATIS, ROBERT
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$198,091
|
Scleroderma
|
NIAMS
|
5U01AR055057-02
|
|
Provisional Combined Response Index For Patients With Diffuse Systemic Sclerosis
|
FURST, DANIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$348,512
|
Scleroderma
|
NIAID
|
1R13AR056207-01
|
|
CIS School in Systemic Autoimmune Diseases
|
TSOKOS, GEORGE
|
CLINICAL IMMUNOLOGY SOCIETY
|
WI
|
$2,500
|
Scleroderma
|
NIAMS
|
1R13AR056207-01
|
|
CIS School in Systemic Autoimmune Diseases
|
TSOKOS, GEORGE
|
CLINICAL IMMUNOLOGY SOCIETY
|
WI
|
$15,000
|
Scleroderma
|
NIAID
|
5R01AR055075-03
|
|
CYTOKINES AS PREDICTORS OF DISEASE PROGRESSION IN SCLERODERMA LUNG DISEASE
|
ROTH, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$155,263
|
Scleroderma
|
NIAMS
|
5R01AR055075-03
|
|
CYTOKINES AS PREDICTORS OF DISEASE PROGRESSION IN SCLERODERMA LUNG DISEASE
|
ROTH, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$168,178
|
Scleroderma
|
NHLBI
|
5K08HL072858-04
|
|
Peripheral Blood Cells in Severe Pulmonary Hypertention
|
BULL, TODD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$132,300
|
Scleroderma
|
NIAMS
|
5K23AR053858-02
|
|
Health Values and Minimally Important Differences in Systemic Sclerosis
|
KHANNA, DINESH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$123,390
|
Scleroderma
|
NIAMS
|
1R01AR055258-01A1
|
|
Two-Stage Genome-Wide Association Study in Systemic Sclerosis
|
MAYES, MAUREEN
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$1,984,223
|
Scleroderma
|
NIAMS
|
1K23AR056303-01
|
|
Assessment in Morphea for the Establishment of Non-Cutaneous Disease (AMEND)
|
JACOBE, HEIDI
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$108,000
|
Scleroderma
|
NIAMS
|
2R01AR050840-05A1
|
|
Mediators of Fibrosis in Scleroderma Skin and Lung
|
FEGHALI-BOSTWICK, CAROL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$333,300
|
Scleroderma
|
NIAMS
|
2R01AR049025-07A1
|
|
Fibroblast TGF-beta/Signaling in Scleroderma: Modulation by PPAR-gamma
|
VARGA, JOHN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$348,571
|
Scleroderma
|
NIAMS
|
1R01AR055634-01A1
|
|
Immunological Mechanisms in Systemic Autoimmune Disease
|
MARSHAK-ROTHSTEIN, ANN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$357,500
|
Scleroderma
|
NHLBI
|
1R01HL089758-01A1
|
|
MOCSLID-CCC
|
TASHKIN, DONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$393,282
|
Scleroderma
|
NHLBI
|
1R01HL089901-01A1
|
|
MOCSLID-DCC
|
ELASHOFF, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$1,887,334
|
Scleroderma
|
NIAMS
|
2R01AR044883-10A2
|
|
TGF-beta receptor signaling in scleroderma
|
TROJANOWSKA, MARIA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$324,500
|
Scleroderma
|
NIAMS
|
1R01AR055660-01A2
|
|
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
|
JIMENEZ, SERGIO
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$339,900
|
Scleroderma
|
NIAMS
|
1R21AR055806-01A1
|
|
Experimental models of scleroderma pathogenesis
|
RAMIREZ, FRANCESCO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$223,740
|
Scleroderma
|
NIAID
|
2R13AR053784-02
|
|
Tenth International Workshop on Scleroderma Research - August 2-6,2008, Cambridge
|
LAFYATIS, ROBERT
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$5,000
|
Scleroderma
|
NIAMS
|
2R13AR053784-02
|
|
Tenth International Workshop on Scleroderma Research - August 2-6,2008, Cambridge
|
LAFYATIS, ROBERT
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$15,000
|
Scleroderma
|
NHLBI
|
1R01HL091745-01A1
|
|
Fibrocyte Phenotypes as Biomarkers in IPFnet Patients
|
MOORE, BETHANY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$347,625
|
Scleroderma
|
NIAMS
|
3R01AR019616-29S1
|
|
Biochemical and Vascular Alterations in Scleroderma
|
JIMENEZ, SERGIO
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$59,672
|
Scleroderma
|
NIAID
|
N01AI05419-15-0-1
|
|
Stem Cell Transplantation for Treatment of Autoimmune Diseases
|
NO PI IDENTIFIED
|
DUKE UNIVERSITY
|
NC
|
$2,115,224
|
Scleroderma
|
NIAMS
|
5P60AR048098-07
|
0007
|
Role of TGF-Beta Genetic Variants in the Pathogenesis of Scleroderma
|
PASCHE, BORIS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$49,096
|
Scleroderma
|
NIAMS
|
5P30AR053503-03
|
9002
|
Genomics/Genotyping
|
BARNES, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$294,363
|
Scleroderma
|
NIAMS
|
5P50AR054144-03
|
0001
|
Functional Genomics Approach to SSc Pathogenesis
|
ARNETT, FRANK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$449,769
|
Scleroderma
|
NIAMS
|
5P50AR054144-03
|
0002
|
Gene Expression as Predictors of Outcome in the GENISOS (Genetics vs Environm
|
MAYES, MAUREEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$425,050
|
Scleroderma
|
NIAMS
|
5P50AR054144-03
|
0003
|
Role of TGF-beta and CTGF Signaling Transgenic Mouse Models of Scleroderma
|
CROMBRUGGHE, BENOIT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$299,503
|
Scleroderma
|
NIAMS
|
5P30AR053503-03
|
0002
|
Granzyme B Genotypes in Scleroderma
|
ANDRADE, FELIPE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$11,610
|
Scleroderma
|
NIAMS
|
5P60AR047785-08
|
9001
|
Methodology Core
|
LAVALLEY, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$392,978
|
Scleroderma
|
NHLBI
|
5P50HL084946-02
|
0001
|
SCLERODERMA-ASSOCIATED PAH
|
HASSOUN, PAUL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$486,269
|
Scleroderma
|
NHLBI
|
5P50HL084946-02
|
0003
|
DYSREGULATED ANGIOGENESIS IN SCLERODERMA-ASSOCIATED PAH
|
WIGLEY, FREDRICK
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$416,957
|
Scleroderma
|
NCRR
|
5M01RR000070-46
|
8014
|
OUTCOME OF SCLERODERMA PATIENTS AT HIGH RISK WITH PULMONARY HYPERTENSION
|
CHUNG, LORINDA
|
STANFORD UNIVERSITY
|
CA
|
$114
|
Scleroderma
|
NCRR
|
5M01RR000070-46
|
8023
|
EFFICACY OF ABATACEPT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS
|
CHAKRAVARTY, ELIZA
|
STANFORD UNIVERSITY
|
CA
|
$2,617
|
Scleroderma
|
NCRR
|
5M01RR000096-47
|
8504
|
CLINICAL TRIAL: T CELL IMMUNITY IN COLLAGEN BIOSYNTHESIS OF SCLERODERMA
|
OLIVER, STEPHEN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$1,489
|
Scleroderma
|
NCRR
|
5M01RR000096-47
|
8518
|
ALTERED DENDRITIC CELL FUNCTION IN SARCOIDOSIS ANERGY
|
OLIVER, STEPHEN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$1,219
|
Scleroderma
|
NCRR
|
5M01RR001346-27
|
8834
|
CENTER FOR RESEARCH TRANSLATION IN SCHLERODERMA
|
FISCHBACH, MICHAEL
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$492
|
Scleroderma
|
NCRR
|
5M01RR023942-02
|
5253
|
EXERCISE ECHOCARDIOGRAMS IN SCLERODERMA
|
STEEN, VIRGINIA
|
GEORGETOWN UNIVERSITY
|
DC
|
$19,976
|
Scleroderma
|
NCRR
|
5M01RR023942-02
|
5264
|
SCOT
|
STEEN, VIRGINIA
|
GEORGETOWN UNIVERSITY
|
DC
|
$713
|
Scleroderma
|
NCRR
|
5M01RR023942-02
|
5267
|
BOSENTAN VS PLACEBO IN NYHA CLASS I/II SCLERODERMA PATIENTS WITH EXERCISE INDUCE
|
STEEN, VIRGINIA
|
GEORGETOWN UNIVERSITY
|
DC
|
$4,281
|
Scleroderma
|
NCRR
|
5M01RR023942-02
|
5295
|
THE OUTCOME OF AFRICAN AMERICAN PATIENTS WITH SCLERODERMA IN RELATIONSHIP TO AUT
|
STEEN, VIRGINIA
|
GEORGETOWN UNIVERSITY
|
DC
|
$1,428
|
Scleroderma
|
NCRR
|
5M01RR000073-45
|
5382
|
OUTCOME IN SYSTEMIC SCLEROSIS:SOCIODEMOGRAPHIC, BEHAVIORAL, IMMUNOGENETIC FACTOR
|
MCNEARNEY, TERRY
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$7,287
|
Scleroderma
|
NCRR
|
2M01RR018535-06
|
5516
|
THE RHEUMATOLOGY SPECIMEN BANK
|
ARANOW, CYNTHIA
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$5,525
|
Scleroderma
|
NCRR
|
5M01RR001070-31
|
5814
|
SUBPROJECT: HLA TYPING AND DNA REPOSITORY
|
SMITH, EDWIN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$775
|
Scleroderma
|
NCRR
|
5M01RR001070-31
|
5824
|
A MULTI-FACETED INVESTIGATION TO IMPROVE ORAL HEALTH IN ADULTS WITH SYSTEMIC
|
YUEN, HON
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$13,950
|
Scleroderma
|
NCRR
|
5M01RR001070-31
|
5833
|
ORAL HEALTH IN PEOPLE WITH SYSTEMIC SCLEROSIS
|
YUEN, HON
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$27,513
|
Scleroderma
|
NIAID
|
1Z01AI001019-02
|
|
Mechanisms of Fibrosis in Asthma and Other Fibroproliferative Diseases
|
WYNN, THOMAS
|
NIH
|
|
$255,255
|
Scleroderma
|
NIAMS
|
1Z01AR041176-01
|
|
Clinical Training in Rheumatology
|
KASTNER, DANIEL
|
NIH
|
|
$1,547,357
|
Scleroderma
|
NCI
|
1Z01BC009369-18
|
|
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
|
OPPENHEIM, JOOST
|
NIH
|
|
$1,023,149
|